REPORTS

Let’s Pullulate and Expand Your Business

Flu Vaccine Market - Global Professional Analysis and Forecast to 2026

Oct 27, 2019  |  171 PAGES  |  REPORT CODE: CMM225529
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Flu Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.1% during the forecast period.

This report presents the market size and development trends by detailing the Flu Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Flu Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Flu Vaccine industry and will help you to build a panoramic view of the industrial development.

Flu Vaccine Market, By Type:

  • Whole virus vaccines

  • Split virus vaccines

  • Subunit or surface antigen vaccines

  • Live attenuated (cold-adapted) virus vaccines

Flu Vaccine Market, By Application:

  • Influenza Vaccine for Children (6 months to 3 years old)

  • Influenza Vaccine for Adult and Children over 3 years

Some of the leading players are as follows:

  • CSL

  • Hualan Bio

  • Novartis

  • CS Vaccine

  • Tiantan Bio

  • Abbott

  • Alephbio

  • Siobp

  • Pfizer

  • GSK

  • Sanofi-pasteur

  • Changchun Bio

  • Tianyuan Bio

  • Sinovac

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Flu Vaccine Market: Technology Type Analysis

  • 4.1 Flu Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Flu Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Whole virus vaccines

    • 4.3.2 Split virus vaccines

    • 4.3.3 Subunit or surface antigen vaccines

    • 4.3.4 Live attenuated (cold-adapted) virus vaccines

5 Flu Vaccine Market: Product Analysis

  • 5.1 Flu Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Flu Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Flu Vaccine Market: Application Analysis

  • 6.1 Flu Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Flu Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Influenza Vaccine for Children (6 months to 3 years old)

    • 6.3.2 Influenza Vaccine for Adult and Children over 3 years

7 Flu Vaccine Market: Regional Analysis

  • 7.1 Flu Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Flu Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 CSL

    • 9.1.1 CSL Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Hualan Bio

    • 9.2.1 Hualan Bio Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 CS Vaccine

    • 9.4.1 CS Vaccine Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Tiantan Bio

    • 9.5.1 Tiantan Bio Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Abbott

    • 9.6.1 Abbott Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Alephbio

    • 9.7.1 Alephbio Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Siobp

    • 9.8.1 Siobp Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Pfizer

    • 9.9.1 Pfizer Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 GSK

    • 9.10.1 GSK Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sanofi-pasteur

    • 9.11.1 Sanofi-pasteur Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Changchun Bio

    • 9.12.1 Changchun Bio Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Tianyuan Bio

    • 9.13.1 Tianyuan Bio Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Sinovac

    • 9.14.1 Sinovac Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 64 Figures and 134 Tables)

  • Figure Whole virus vaccines Flu Vaccine market, 2015 - 2026 (USD Million)

  • Figure Split virus vaccines Flu Vaccine market, 2015 - 2026 (USD Million)

  • Figure Subunit or surface antigen vaccines Flu Vaccine market, 2015 - 2026 (USD Million)

  • Figure Live attenuated (cold-adapted) virus vaccines Flu Vaccine market, 2015 - 2026 (USD Million)

  • Figure Influenza Vaccine for Children (6 months to 3 years old) market, 2015 - 2026 (USD Million)

  • Figure Influenza Vaccine for Adult and Children over 3 years market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Flu Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Flu Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Flu Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Flu Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Flu Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Flu Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Flu Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Flu Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table CSL Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CS Vaccine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tiantan Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alephbio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siobp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi-pasteur Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Changchun Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tianyuan Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sinovac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top